Navigation Links
Rapid eye movements significantly delayed in people with glaucoma
Date:12/6/2012

TORONTO, DEC. 6, 2012Rapid eye movements are significantly delayed in patients with glaucoma, even those in the early stages of the disease, research has found.

The findings, led by Dr. Neeru Gupta, an ophthalmologist at St. Michael's Hospital, may shed new light on why glaucoma patients are at increased risk for falls and car accidents. Glaucoma is the leading cause of irreversible blindness.

Rapid (or saccadic) eye movements are the quick, simultaneous movements of both eyes in the same direction. They are involved in a myriad of everyday activities, from reading to scanning the surrounding environment, be it a busy subway station, grocery store shelves or oncoming traffic.

Dr. Gupta and co-workers studied groups of people with and without glaucoma who wore a head-mounted device that measured the length of time it took their eyes to move from one point to another, how long it took their eyes to begin the movement, did they focus on an object right away or did their eyes overshoot the target.

"Most of us take that processing of information for granted," she said.

However, she found that people with glaucoma showed delayed eye movement reaction times by about 15 per cent, even if they were in the early stages of the disease.

The findings were published online in the journal Eye and Brain.

Dr. Gupta said the findings are significant because they suggest that approaches to measuring vision loss beyond eye charts or visual field tests that related to real world settings may provide important clues to how the disease affects the lives of glaucoma patients. Glaucoma is becoming more common as the population ages and is expected to affect 80 million people worldwide by 2020. About half of all cases remain undiagnosed.

Currently, glaucoma can be diagnosed only by using a light to examine the optic nerve. Eye charts will not catch glaucoma, because it begins with peripheral vision loss long before reaching central vision.

All treatments for glaucoma -- eye drops, laser surgery and conventional surgery -- are designed to reduce pressure in the eye and help slow or stabilize damage to optic nerve. No treatment can reverse the disease.

"Now that we know that eye movement reaction times are delayed in people with glaucoma, there is an opportunity to understand the effects of glaucoma on daily activities of living that most of us take for granted, such as walking up and down stairs, driving, navigating and reading. Dr. Gupta said. "Just as alcohol causes a delay in hitting the brakes, glaucoma slows the time it takes to move the eyes quickly in response to a visual cue."

In previous work, Dr. Gupta and colleagues have demonstrated that glaucoma is a neurodegenerative disease affecting major vision pathways in the brain. Dr. Gupta's current paper points to a new vision pathway in the brain that is affected in glaucoma. Ninety per cent of signals from the optic nerve travel to an area at the back of the brain called the lateral geniculate nucleus. But the brain signals for rapid eye movements appear to travel a different route through the area known as the superior colliculus. A previous smaller study by Lamirel and coworkers published in the Journal of Glaucoma in 2012 also showed that saccades were impaired in four glaucoma patients with visual field loss.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-4094
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. Satellite observes rapid ice shelf disintegration in Antarctic
2. Rapid Asthma Treatment in ER May Prevent Admission
3. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
4. OnPage Provides Secure, Rapid Response at New England’s Largest Catholic Hospital
5. UGA researchers develop rapid diagnostic test for pathogens, contaminants
6. Strawberry birthmarks grow rapidly when babies just weeks old, Mayo Clinic finds
7. Obesity in Middle Age Tied to More Rapid Mental Decline: Study
8. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
9. New opportunity for rapid treatment of malaria
10. Integrated diabetes management program provides rapid improvements in patient care
11. Experts urge rapid evaluation for swallowing and voice problems after brain surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... pleased to announce the launch of a months-long rebranding effort. This includes the ... , “Through focus group discussions and market research, we learned that a simple, ...
(Date:3/27/2017)... ... 27, 2017 , ... Harris Communications, Inc., a leading provider of assistive ... to the Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria ... ASL friendly staff from Harris Communications and to try out the newest assistive devices ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established ... same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four ... prehospital trauma education developed in cooperation with the American College of Surgeons to ...
(Date:3/24/2017)... , ... March 24, 2017 , ... According to a ... is invalid because it does not obey the rules Congress has directed the CBO ... jobs, which the GOP reform would restore. Yet, it estimates a reduction in employer-based ...
(Date:3/24/2017)... Calif. (PRWEB) , ... March 24, 2017 , ... ... raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... instant demand for the product – with nearly 2,000 consumers (and counting) already ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  iCAD (Nasdaq: ICAD), ... solutions and radiation therapy for the early identification ... Tomo Detection received Premarket Approval (PMA) from the ... Detection is a first-of-its-kind, concurrent-read computer aided detection ... the latest innovation available on the PowerLook® Breast ...
(Date:3/27/2017)... 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced ... M. Bisaro as Impax,s President and Chief Executive ... March 27, 2017. Mr. Bisaro will succeed J. ... and Chief Executive Officer since December of 2016. ... pharmaceutical experience, Mr. Bisaro, 56, is an accomplished global ...
(Date:3/27/2017)... March 27, 2017   Genprex, Inc. , a privately held, ... Pham , MD, the Company,s Chief Operating Officer, is scheduled to ... Sachs 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, ... York, NY ... BioCentury 24th Annual Future Leaders in Biotech Industry – ...
Breaking Medicine Technology: